Loading, Please Wait...
PITTSBURGH, March 04, 2019 (GLOBE NEWSWIRE) -- GNC Holdings, Inc. (NYSE: GNC), a leading global health and wellness brand, will release results for the fourth quarter of 2018 before the market opens on March 5, 2019. The Company will be holding the conference call sooner than previously expected. A webcast and conference call to discuss the results will be held at 8:30 am Eastern Time that day.
To participate on the live call listeners in North America may dial 1-888-254-3590 and international listeners may dial 1-323-994-2093. It is encouraged that callers dial in 5-10 minutes prior to the start of the call. In addition, a live webcast of the call will be available on www.gnc.com via the Investor Relations section under "About GNC." A replay of this webcast will be available through March 19, 2019.
GNC Holdings, Inc. (NYSE: GNC) - is a global health and wellness brand that helps people live well. The company is known and trusted for quality performance and nutritional supplements, and its broad assortment features innovative private-label products as well as national recognized third-party brands, many of which are exclusive to GNC.
GNC’s diversified, multi-channel business model has global reach and a well-recognized, trusted brand, and provides customers with excellent service, product knowledge and solutions. The company reaches consumers worldwide through company-owned retail locations, and domestic and international franchise activities, and e-commerce. GNC also has exceptional innovation and product development capabilities, manufactures products for third parties and generates revenue through corporate partnerships. As of September 30, 2018, GNC had approximately 8,500 locations, of which approximately 6,400 retail locations are in the United States (including approximately 2,200 Rite Aid franchise store-within-a-store locations) and franchise operations in approximately 50 countries.
Matt Milanovich, VP - Investor Relations & Treasury, (412) 402-7260; or
John Mills, Managing Partner – ICR, (646) 277-1254